Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Kenney

Showing results (521-530 of 525) with videos related to

Pageof 53
Sort By:
You have reached the last page of results.This site can display upto 525 results.
JCO Precision Oncology|November 7, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic SignificanceKathleen Conway, Sharon N Edmiston, Amanda Vondras, et al.
Plos One|April 3, 2023
InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanomaIrene Orlow, Keimya D Sadeghi, Sharon N Edmiston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III MelanomaJennifer M Wiggins, Qiao Zhang, Yian Zhang, et al.
Nature Genetics|January 3, 2025
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lipJohn J Y Lee, Ran Tao, Zhen You, et al.
Nature|July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomesPaul A Northcott, David J H Shih, John Peacock, et al.
Pageof 53

Showing results (521-530 of 525) with videos related to

Sort By:
Pageof 53
You have reached the last page of results.This site can display upto 525 results.
JCO Precision Oncology|November 7, 2024
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic SignificanceKathleen Conway, Sharon N Edmiston, Amanda Vondras, et al.
Plos One|April 3, 2023
InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanomaIrene Orlow, Keimya D Sadeghi, Sharon N Edmiston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2025
Tumor miRNA Signatures Associate with Outcomes of Patients with Stage II/III MelanomaJennifer M Wiggins, Qiao Zhang, Yian Zhang, et al.
Nature Genetics|January 3, 2025
ZIC1 is a context-dependent medulloblastoma driver in the rhombic lipJohn J Y Lee, Ran Tao, Zhen You, et al.
Nature|July 27, 2012
Subgroup-specific structural variation across 1,000 medulloblastoma genomesPaul A Northcott, David J H Shih, John Peacock, et al.
Pageof 53